Commodity-linked stocks drag FTSE 100 lower; AstraZeneca jumps

(For a Reuters live blog on U.S., UK and European stock markets, click

or type LIVE/ in a news window)


FTSE 100 down 0.1%, FTSE 250 off 0.3%

Nov 10 (Reuters) - UK's blue-chip FTSE 100 index fell on Thursday, as miners and oil giants tracked losses in commodity prices, although a strong performance by drugmaker AstraZeneca following an upbeat forecast helped cap losses ahead of key U.S. inflation data.

The large-cap FTSE 100 .FTSE dipped 0.1% by 0822 GMT. The mid-cap FTSE 250 .FTMC shed 0.3%.

Energy firms .FTNMX601010 and miners .FTNMX551030 fell 1% and 1.3%, respectively, tracking prices of oil and metals that were hit by a stronger U.S. dollar.

Shares of AstraZeneca AZN.L jumped 1.5% after the drugmaker raised its full-year adjusted earnings forecast, helped by sales of its roster of cancer drugs. The wider pharmaceuticals sector .FTNMX201030 rose 1.2%.

The U.S. consumer prices data is likely to show an easing in the monthly and yearly core numbers for October to 0.5% and 6.5%, respectively, according to a Reuters poll.

WH Smith SMWH.L climbed 4.1% after the company reinstated dividends and posted an annual profit, supported by a post-pandemic travel rebound.
Reporting by Johann M Cherian in Bengaluru; Editing by Sherry Jacob-Phillips

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.